The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel Topical Ketamine Delivery.

Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes and Negate Side Effects

Ardelyx (ARDX) Resubmits New Drug Application to FDA.

WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop...

Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.

Rick Doblin, Recently Visited one of Psycheceutical's Labs. Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted...
ARDX, Roland Rick Perry

And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.

LIVE QUOTE Longer Term Chart Ardelyx Enters the Danger Zone* With Tenapanor.

Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.

If we average out the two most recent price targets this month, we come out with a potential gain of 337% and...

Hidden Gem and a Monster in the Making? Beasley Broadcast Group (BBGI) $0.80

If They Simply Changed Their Name to Beasley Internet Group, it Could be Revalued 3-Fold Higher. We...

Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...

Topline Results anticipated by the end of Q2 2023 CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or...

Smart for Life (SMFL) Reports Revenue Increases 96.9% to $17.8 Million for 2022

Smart for Life Reports 2022 Financial Results and Provides Business Update (Bolding by IA Editor)

Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.

Think Equity: Society Pass (Nasdaq: SOPA) – Path to Profitability NEW YORK, NY, March 14, 2023 (GLOBE NEWSWIRE) --...

And We Have a $26.4 Billion Winning Trifecta!

THREE PREVIOUS WINNERS* Immunomedics (IMMU) $3 to $87 up 2,800%, a gain of $20.7 billion. Acquired...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...